Literature DB >> 10331421

Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations.

H Sakamaki1, S Akazawa, M Ishibashi, K Izumino, H Takino, H Yamasaki, Y Yamaguchi, S Goto, Y Urata, T Kondo, S Nagataki.   

Abstract

Hyperglycemia-induced embryonic malformations may be due to an increase in radical formation and depletion of intracellular glutathione (GSH) in embryonic tissues. In the past, we have investigated the role of the glutathione-dependent antioxidant system and GSH on diabetes-related embryonic malformations. Embryos from streptozotocin-induced diabetic rats on gestational day 11 showed a significantly higher frequency of embryonic malformations (neural lesions 21.5 vs. 2.8%, P<0.001; nonneural lesions 47.4 vs. 6.4%, P<0.001) and growth retardation than those of normal mothers. The formation of intracellular reactive oxygen species (ROS), estimated by flow cytometry, was increased in isolated embryonic cells of diabetic rats on gestational day 11. The concentration of intracellular GSH in embryonic tissues of diabetic pregnant rats on day 11 was significantly lower than that of normal rats. The activity of y-glutamylcysteine synthetase (gamma-GCS), the rate-limiting GSH synthesizing enzyme, in embryos of diabetic rats was significantly low, associated with reduced expression of gamma-GCS mRNA. Administration of buthionine sulfoxamine (BSO), a specific inhibitor of gamma-GCS, to diabetic rats during the period of maximal teratogenic susceptibility (days 6-11 of gestation) reduced GSH by 46.7% and increased the frequency of neural lesions (62.1 vs. 21.5%, P<0.01) and nonneural lesions (79.3 vs. 47.4%, P<0.01). Administration of GSH ester to diabetic rats restored GSH concentration in the embryos and reduced the formation of ROS, leading to normalization of neural lesions (1.9 vs. 21.5%) and improvement in nonneural lesions (26.7 vs. 47.4%) and growth retardation. Administration of insulin in another group of pregnant rats during the same period resulted in complete normalization of neural lesions (4.3 vs. 21.5%), nonneural lesions (4.3 vs. 47.4%), and growth retardation with the restoration of GSH contents. Our results indicate that GSH depletion and impaired responsiveness of GSH-synthesizing enzyme to oxidative stress during organogenesis may have important roles in the development of embryonic malformations in diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331421     DOI: 10.2337/diabetes.48.5.1138

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  44 in total

Review 1.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Impaired reductive regeneration of ascorbic acid in the Goto-Kakizaki diabetic rat.

Authors:  M Kashiba; J Oka; R Ichikawa; A Kageyama; T Inayama; H Kageyama; T Ishikawa; M Nishikimi; M Inoue; S Inoue
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 3.  Oxidative stress, unfolded protein response, and apoptosis in developmental toxicity.

Authors:  Allison Kupsco; Daniel Schlenk
Journal:  Int Rev Cell Mol Biol       Date:  2015-03-11       Impact factor: 6.813

Review 4.  Diabetic embryopathy: a role for the epigenome?

Authors:  J Michael Salbaum; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-02

5.  SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.

Authors:  Hongbo Weng; Xuezheng Li; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2012-02-22       Impact factor: 8.661

6.  Amniotic coenzyme Q10: is it related to pregnancy outcomes?

Authors:  Stefano Raffaele Giannubilo; Luca Tiano; Andrea Ciavattini; Beatrice Landi; Paola Carnevali; Federica Principi; Gian Paolo Littarru; Laura Mazzanti
Journal:  Antioxid Redox Signal       Date:  2014-06-25       Impact factor: 8.401

7.  Role of HIF-1α in maternal hyperglycemia-induced embryonic vasculopathy.

Authors:  Peixin Yang; E Albert Reece
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

8.  Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model.

Authors:  Denise S Hill; Bogdan J Wlodarczyk; Laura E Mitchell; Richard H Finnell
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-14       Impact factor: 4.219

9.  Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes.

Authors:  Y Sugimura; T Murase; K Oyama; A Uchida; N Sato; S Hayasaka; Y Kano; Y Takagishi; Y Hayashi; Y Oiso; Y Murata
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

10.  Maternal diabetes alters transcriptional programs in the developing embryo.

Authors:  Gabriela Pavlinkova; J Michael Salbaum; Claudia Kappen
Journal:  BMC Genomics       Date:  2009-06-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.